Open Access
Open access
volume 40 issue D1 pages D1100-D1107

ChEMBL: a large-scale bioactivity database for drug discovery

Publication typeJournal Article
Publication date2011-09-23
scimago Q1
wos Q1
SJR7.776
CiteScore31.7
Impact factor13.1
ISSN03051048, 13624962
PubMed ID:  21948594
Genetics
Abstract
ChEMBL is an Open Data database containing binding, functional and ADMET information for a large number of drug-like bioactive compounds. These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chemical biology and drug-discovery research problems. Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compounds and 5200 protein targets. Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.
Found 
Found 

Top-30

Journals

50
100
150
200
250
300
350
Journal of Chemical Information and Modeling
335 publications, 9.66%
Journal of Cheminformatics
134 publications, 3.86%
Journal of Medicinal Chemistry
85 publications, 2.45%
Molecular Informatics
71 publications, 2.05%
Journal of Computer-Aided Molecular Design
61 publications, 1.76%
Scientific Reports
59 publications, 1.7%
International Journal of Molecular Sciences
54 publications, 1.56%
PLoS ONE
54 publications, 1.56%
Briefings in Bioinformatics
50 publications, 1.44%
Bioinformatics
49 publications, 1.41%
Molecules
45 publications, 1.3%
Molecular Diversity
44 publications, 1.27%
ACS Omega
42 publications, 1.21%
Methods in Molecular Biology
41 publications, 1.18%
Nucleic Acids Research
39 publications, 1.12%
European Journal of Medicinal Chemistry
37 publications, 1.07%
BMC Bioinformatics
36 publications, 1.04%
Computers in Biology and Medicine
35 publications, 1.01%
Frontiers in Pharmacology
32 publications, 0.92%
Future Medicinal Chemistry
30 publications, 0.87%
Journal of Biomolecular Structure and Dynamics
30 publications, 0.87%
Drug Discovery Today
29 publications, 0.84%
F1000Research
27 publications, 0.78%
Nature Communications
27 publications, 0.78%
Expert Opinion on Drug Discovery
24 publications, 0.69%
Bioorganic and Medicinal Chemistry
23 publications, 0.66%
ChemMedChem
21 publications, 0.61%
MedChemComm
21 publications, 0.61%
RSC Advances
21 publications, 0.61%
50
100
150
200
250
300
350

Publishers

100
200
300
400
500
600
700
800
Springer Nature
709 publications, 20.44%
American Chemical Society (ACS)
596 publications, 17.19%
Elsevier
564 publications, 16.26%
Wiley
271 publications, 7.81%
MDPI
194 publications, 5.59%
Oxford University Press
172 publications, 4.96%
Cold Spring Harbor Laboratory
132 publications, 3.81%
Taylor & Francis
128 publications, 3.69%
Royal Society of Chemistry (RSC)
116 publications, 3.34%
Institute of Electrical and Electronics Engineers (IEEE)
100 publications, 2.88%
Frontiers Media S.A.
82 publications, 2.36%
Public Library of Science (PLoS)
78 publications, 2.25%
Bentham Science Publishers Ltd.
42 publications, 1.21%
F1000 Research
27 publications, 0.78%
SAGE
15 publications, 0.43%
Hindawi Limited
12 publications, 0.35%
Mary Ann Liebert
11 publications, 0.32%
AIP Publishing
7 publications, 0.2%
PeerJ
7 publications, 0.2%
eLife Sciences Publications
7 publications, 0.2%
American Association for the Advancement of Science (AAAS)
7 publications, 0.2%
Proceedings of the National Academy of Sciences (PNAS)
7 publications, 0.2%
Association for Computing Machinery (ACM)
6 publications, 0.17%
IGI Global
6 publications, 0.17%
IOP Publishing
6 publications, 0.17%
American Society for Pharmacology and Experimental Therapeutics
5 publications, 0.14%
Impact Journals
5 publications, 0.14%
World Scientific
5 publications, 0.14%
Walter de Gruyter
5 publications, 0.14%
100
200
300
400
500
600
700
800
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
3.5k
Share
Cite this
GOST |
Cite this
GOST Copy
Gaulton A. et al. ChEMBL: a large-scale bioactivity database for drug discovery // Nucleic Acids Research. 2011. Vol. 40. No. D1. p. D1100-D1107.
GOST all authors (up to 50) Copy
Gaulton A. ChEMBL: a large-scale bioactivity database for drug discovery // Nucleic Acids Research. 2011. Vol. 40. No. D1. p. D1100-D1107.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1093/nar/gkr777
UR - https://doi.org/10.1093/nar/gkr777
TI - ChEMBL: a large-scale bioactivity database for drug discovery
T2 - Nucleic Acids Research
AU - Gaulton, Anna
PY - 2011
DA - 2011/09/23
PB - Oxford University Press
SP - D1100-D1107
IS - D1
VL - 40
PMID - 21948594
SN - 0305-1048
SN - 1362-4962
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2011_Gaulton,
author = {Anna Gaulton},
title = {ChEMBL: a large-scale bioactivity database for drug discovery},
journal = {Nucleic Acids Research},
year = {2011},
volume = {40},
publisher = {Oxford University Press},
month = {sep},
url = {https://doi.org/10.1093/nar/gkr777},
number = {D1},
pages = {D1100--D1107},
doi = {10.1093/nar/gkr777}
}
MLA
Cite this
MLA Copy
Gaulton, Anna, et al. “ChEMBL: a large-scale bioactivity database for drug discovery.” Nucleic Acids Research, vol. 40, no. D1, Sep. 2011, pp. D1100-D1107. https://doi.org/10.1093/nar/gkr777.